CANDESARTAN Amlodipine Sandoz caps 8/5mg 28 pce

7680688600018 CH-68860 C09DB07 02.07.1.

Reimbursement limitations:

CANDESART-AM

Le traitement combiné d’une association fixe de candésartan et amlodipine et d'un antagoniste du calcium …

CANDESARTAN Amlodipine Sandoz caps 8/5mg 28 pce
CANDESARTAN Amlodipine Sandoz caps 8/5mg 28 pce
CANDESARTAN Amlodipine Sandoz caps 8/5mg 28 pce
1 / 3
google

Details

Product number
6886001
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
candesartanum cilexetilum 8 mg, amlodipinum 5 mg ut amlodipini besilas, lactosum monohydricum 101.95 mg, maydis amylum, carmellosum calcicum, macrogolum 8000, hydroxypropylcellulosum, magnesii stearas, Kapselhülle: E 104, E 172 (flavum), E 171, gelatina, pro capsula.

Articles (1)

Candesartan Amlodipin Sandoz 8 mg/5 mg , Hartkapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/10/2025
Patient information leaflet
Français
16/10/2025
Patient information leaflet
Italien
16/10/2025
Professional SmPC
Allemand
16/10/2025
Professional SmPC
Français
16/10/2025
Professional SmPC
Italien
16/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
8.0 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
101.95 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 32.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2024

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
68860
Drug name
Candesartan Amlodipin Sandoz, Hartkapseln
Galenic form
KAHA
ATC Code
C09DB07
Authorization status
Z
Dispensation category
B
First authorization
06/06/2024
Authorization expiration date
05/06/2029
IT number
02.07.1.
Domain
Human medicine
Field of application
Essentielle Hypertonie

Packaging details

Description (FR)
CANDESARTAN Amlodipine Sandoz caps 8/5mg 28 pce
Description (DE)
CANDESARTAN Amlodipin Sandoz Kaps 8/5mg 28 Stk
Market launch
06/06/2024
Narcotic (BTM)
No

Other packaging sizes

CANDESARTAN Amlodipine Sandoz caps 8/5mg 98 pce
98 KAP
View
CANDESARTAN Amlodipine Sandoz caps 8/10mg 28 pce
28 KAP
View
CANDESARTAN Amlodipine Sandoz caps 8/10mg 98 pce
98 KAP
View
CANDESARTAN Amlodipine Sandoz caps 16/5mg 28 pce
28 KAP
View
CANDESARTAN Amlodipine Sandoz caps 16/5mg 98 pce
98 KAP
View
CANDESARTAN Amlodipine Sandoz caps 16/10mg 28 pce
28 KAP
View
CANDESARTAN Amlodipine Sandoz caps 16/10mg 98 pce
98 KAP
View